RIVAROXABAN

Product NDC
70756-006
Requested package NDC
70756-006-81
11-digit product format
707560006
Labeler code
70756
Product ID
70756-006_0438bd24-fd5f-476b-a7e8-eeab15f3551b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rivaroxaban
Dosage form
TABLET
Route
ORAL
Labeler
Lifestar Pharma LLC
Application
ANDA220874
Marketing category
ANDA
Marketing start
2026-10-01
Substance
RIVAROXABAN
Active strength
2.5 mg/1
Pharmacologic classes
Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220874-001RIVAROXABANRIVAROXABAN2.5MGTABLET / ORALAB2026-07-01
A220874-002RIVAROXABANRIVAROXABAN10MGTABLET / ORALAB2026-07-01
A220874-003RIVAROXABANRIVAROXABAN15MGTABLET / ORALAB2026-07-01
A220874-004RIVAROXABANRIVAROXABAN20MGTABLET / ORALAB2026-07-01

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-productTE code
A220874-001AB
A220874-002AB
A220874-003AB
A220874-004AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220874-001RIVAROXABAN2.5MGTABLET / ORALAB2026-07-01d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-002RIVAROXABAN10MGTABLET / ORALAB2026-07-01d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-003RIVAROXABAN15MGTABLET / ORALAB2026-07-01d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-004RIVAROXABAN20MGTABLET / ORALAB2026-07-01d4dbc9d85df4…
2026-10-15 13:18:302026-09A220874-001RIVAROXABAN2.5MGTABLET / ORALAB2026-07-01c2088c7a36db…
2026-10-15 13:18:302026-09A220874-002RIVAROXABAN10MGTABLET / ORALAB2026-07-01c2088c7a36db…
2026-10-15 13:18:302026-09A220874-003RIVAROXABAN15MGTABLET / ORALAB2026-07-01c2088c7a36db…
2026-10-15 13:18:302026-09A220874-004RIVAROXABAN20MGTABLET / ORALAB2026-07-01c2088c7a36db…
2026-09-14 22:38:342026-08A220874-001RIVAROXABAN2.5MGTABLET / ORALAB2026-07-0184e616aacf4f…
2026-09-14 22:38:342026-08A220874-002RIVAROXABAN10MGTABLET / ORALAB2026-07-0184e616aacf4f…
2026-09-14 22:38:342026-08A220874-003RIVAROXABAN15MGTABLET / ORALAB2026-07-0184e616aacf4f…
2026-09-14 22:38:342026-08A220874-004RIVAROXABAN20MGTABLET / ORALAB2026-07-0184e616aacf4f…
2026-08-18 06:07:402026-07A220874-001RIVAROXABAN2.5MGTABLET / ORALAB2026-07-01caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-002RIVAROXABAN10MGTABLET / ORALAB2026-07-01caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-003RIVAROXABAN15MGTABLET / ORALAB2026-07-01caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-004RIVAROXABAN20MGTABLET / ORALAB2026-07-01caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-001RIVAROXABAN2.5MGTABLET / ORALAB2026-07-01a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-002RIVAROXABAN10MGTABLET / ORALAB2026-07-01a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-003RIVAROXABAN15MGTABLET / ORALAB2026-07-01a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-004RIVAROXABAN20MGTABLET / ORALAB2026-07-01a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A220874-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-003AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A220874-004AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A220874-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220874-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220874-003AB1c2088c7a36db…
2026-10-15 13:18:302026-09A220874-004AB1c2088c7a36db…
2026-09-14 22:38:342026-08A220874-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A220874-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A220874-003AB184e616aacf4f…
2026-09-14 22:38:342026-08A220874-004AB184e616aacf4f…
2026-08-18 06:07:402026-07A220874-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-003AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A220874-004AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-003AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A220874-004AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
RIVAROXABAN
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RIVAROXABAN2.5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
9NDF7JZ4M3Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2059015Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d6de1719-6fbd-4386-9f81-d65980dc4bd8Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIVAROXABANRIVAROXABANLifestar Pharma LLCd6de1719-6fbd-4386-9f81-d65980dc4bd82026-07-17Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220874
application number: ANDA220874
ndc (package): 70756-006-81
ndc (product): 70756-006
ndc11 (package): 70756000681

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
70756-006-8170756000681180 TABLET in 1 BOTTLE (70756-006-81) 180 tablet2026-10-01NoNoCurrent